Localized nodular pemphigoid.
Yoneda K, Ishii N, Nakai K, Kubota Y, Hashimoto T.
Int J Dermatol. 2018 May;57(5):587-589. doi: 10.1111/ijd.13889. Epub 2018 Jan 10.
Nodular formation in anti-laminin gamma1 pemphigoid.
Tomura Y, Noto M, Ishii N, Hashimoto T, Manabe M, Osada SI.
J Dermatol. 2020 Mar;47(3):e80-e82. doi: 10.1111/1346-8138.15227. Epub 2020 Jan 8.
Nodular Subtype of Bullous Pemphigoid.
Dangel B, Kofler L, Metzler G.
J Cutan Med Surg. 2016 Nov;20(6):570-572. doi: 10.1177/1203475416648322. Epub 2016 May 4.
Pemphigoid nodularis.
Yung CW, Soltani K, Lorincz AL.
J Am Acad Dermatol. 1981 Jul;5(1):54-60. doi: 10.1016/s0190-9622(81)70077-x.
Case Report: Pemphigoid Nodularis-Five Patients With Many Years of Follow-Up and Review of the Literature.
Szymanski K, Adaszewska A, Jakubowska B, Kowalewski C, Pietrzyk E, Wozniak K.
Front Immunol. 2022 Apr 12;13:885023. doi: 10.3389/fimmu.2022.885023. eCollection 2022.
Coexistence of nodular and dyshidrosiform pemphigoid.
Seike M, Nakajima K, Ikeda M, Kodama H.
J Dermatol. 2006 May;33(5):375-6. doi: 10.1111/j.1346-8138.2006.00086.x.
IL-27 as a novel biomarker for pruritus in nodular prurigo and bullous pemphigoid.
Wang Y, Zhang X, Teng YT, Shen C.
Front Immunol. 2024 Dec 13;15:1499868. doi: 10.3389/fimmu.2024.1499868. eCollection 2024.
Non-Bullous Pemphigoid: A Single-Center Retrospective Study.
Moar A, Azzolini A, Tessari G, Schena D, Girolomoni G.
Dermatology. 2021;237(6):1039-1045. doi: 10.1159/000515954. Epub 2021 May 12.
Bullous pemphigoid: from bench to bedside.
Walsh SR, Hogg D, Mydlarski PR.
Drugs. 2005;65(7):905-26. doi: 10.2165/00003495-200565070-00002.
Atypical presentations of bullous pemphigoid: Clinical and immunopathological aspects.
Cozzani E, Gasparini G, Burlando M, Drago F, Parodi A.
Autoimmun Rev. 2015 May;14(5):438-45. doi: 10.1016/j.autrev.2015.01.006. Epub 2015 Jan 21.
